The Impact of and Adaptations Due to the COVID-19 Pandemic on the Histopathological Diagnosis of Skin Pathologies, Including Non-Melanocyte and Melanoma Skin Cancers—A Single-Center Study in Romania

<i>Background and Objectives</i>: The COVID-19 pandemic has globally affected health systems and services. Non-melanoma skin cancers (NMSCs) are the most common malignancies around the world. This study aimed to analyze the differences in the benign and malignant histopathological diagno...

Full description

Bibliographic Details
Main Authors: Iuliu-Gabriel Cocuz, Maria-Elena Cocuz, Raluca Niculescu, Mihaela Cornelia Șincu, Andreea Cătălina Tinca, Adrian-Horațiu Sabău, Diana Maria Chiorean, Silviu Horia Morariu, Ovidiu Simion Cotoi
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/57/6/533
_version_ 1827691403060183040
author Iuliu-Gabriel Cocuz
Maria-Elena Cocuz
Raluca Niculescu
Mihaela Cornelia Șincu
Andreea Cătălina Tinca
Adrian-Horațiu Sabău
Diana Maria Chiorean
Silviu Horia Morariu
Ovidiu Simion Cotoi
author_facet Iuliu-Gabriel Cocuz
Maria-Elena Cocuz
Raluca Niculescu
Mihaela Cornelia Șincu
Andreea Cătălina Tinca
Adrian-Horațiu Sabău
Diana Maria Chiorean
Silviu Horia Morariu
Ovidiu Simion Cotoi
author_sort Iuliu-Gabriel Cocuz
collection DOAJ
description <i>Background and Objectives</i>: The COVID-19 pandemic has globally affected health systems and services. Non-melanoma skin cancers (NMSCs) are the most common malignancies around the world. This study aimed to analyze the differences in the benign and malignant histopathological diagnoses performed on radical excision skin tumors and skin biopsies in the dermatopathology ward in Mures Clinical County Hospital, Targu Mures, Romania, 1 year prior to and during the COVID-19 pandemic, to emphasize the changes in the diagnostic process as per the new regulations. <i>Materials and Methods:</i> A total of 1168 histopathological diagnoses were included in the study—302 from the COVID-19 period and 866 from the non-COVID-19 period—considering the number, type, and frequency of the histopathological diagnoses as variables to be analyzed. <i>Results</i>: In the COVID-19 period, out of the 55 NMSC and melanoma histopathological diagnoses, 50.9% (<i>n</i> = 28) were BCCs, 20% (<i>n</i> = 11) were SCCs, 10.9% (<i>n</i> = 6) were basosquamous cell carcinomas, and 18.18% (<i>n</i> = 10) were melanoma cases. Regarding the non-COVID-19 period, out of the 173 NMSC and melanoma histopathological diagnoses, 46.82% (<i>n</i> = 81) were BCCs, 22.54% (<i>n</i> = 39) were SCCs, 7.51% (<i>n</i> = 13) were basosquamous cell carcinomas, and 23.12% (<i>n</i> = 40) were melanoma cases. <i>Conclusions:</i> During the COVID-19 pandemic, a decrease in histopathological diagnoses at the dermatopathology ward in our hospital was observed, for both benign and malignant pathologies, especially for NMSCs and melanomas, compared to the same period 1 year prior to the pandemic.
first_indexed 2024-03-10T11:00:14Z
format Article
id doaj.art-295cc205f9e24676aeead6a20d8fcc96
institution Directory Open Access Journal
issn 1010-660X
1648-9144
language English
last_indexed 2024-03-10T11:00:14Z
publishDate 2021-05-01
publisher MDPI AG
record_format Article
series Medicina
spelling doaj.art-295cc205f9e24676aeead6a20d8fcc962023-11-21T21:33:35ZengMDPI AGMedicina1010-660X1648-91442021-05-0157653310.3390/medicina57060533The Impact of and Adaptations Due to the COVID-19 Pandemic on the Histopathological Diagnosis of Skin Pathologies, Including Non-Melanocyte and Melanoma Skin Cancers—A Single-Center Study in RomaniaIuliu-Gabriel Cocuz0Maria-Elena Cocuz1Raluca Niculescu2Mihaela Cornelia Șincu3Andreea Cătălina Tinca4Adrian-Horațiu Sabău5Diana Maria Chiorean6Silviu Horia Morariu7Ovidiu Simion Cotoi8Doctoral School of Medicine and Pharmacy, George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures, 540142 Targu Mures, RomaniaFundamental Prophylactic and Clinical Disciplines Department, Faculty of Medicine, Transilvania University of Brasov, 500003 Brașov, RomaniaDoctoral School of Medicine and Pharmacy, George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures, 540142 Targu Mures, RomaniaDoctoral School of Medicine and Pharmacy, George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures, 540142 Targu Mures, RomaniaDoctoral School of Medicine and Pharmacy, George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures, 540142 Targu Mures, RomaniaDoctoral School of Medicine and Pharmacy, George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures, 540142 Targu Mures, RomaniaPathology Department, Mures Clinical County Hospital, 540011 Targu Mures, RomaniaDermatology Department, George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures, 540142 Targu Mures, RomaniaPathology Department, Mures Clinical County Hospital, 540011 Targu Mures, Romania<i>Background and Objectives</i>: The COVID-19 pandemic has globally affected health systems and services. Non-melanoma skin cancers (NMSCs) are the most common malignancies around the world. This study aimed to analyze the differences in the benign and malignant histopathological diagnoses performed on radical excision skin tumors and skin biopsies in the dermatopathology ward in Mures Clinical County Hospital, Targu Mures, Romania, 1 year prior to and during the COVID-19 pandemic, to emphasize the changes in the diagnostic process as per the new regulations. <i>Materials and Methods:</i> A total of 1168 histopathological diagnoses were included in the study—302 from the COVID-19 period and 866 from the non-COVID-19 period—considering the number, type, and frequency of the histopathological diagnoses as variables to be analyzed. <i>Results</i>: In the COVID-19 period, out of the 55 NMSC and melanoma histopathological diagnoses, 50.9% (<i>n</i> = 28) were BCCs, 20% (<i>n</i> = 11) were SCCs, 10.9% (<i>n</i> = 6) were basosquamous cell carcinomas, and 18.18% (<i>n</i> = 10) were melanoma cases. Regarding the non-COVID-19 period, out of the 173 NMSC and melanoma histopathological diagnoses, 46.82% (<i>n</i> = 81) were BCCs, 22.54% (<i>n</i> = 39) were SCCs, 7.51% (<i>n</i> = 13) were basosquamous cell carcinomas, and 23.12% (<i>n</i> = 40) were melanoma cases. <i>Conclusions:</i> During the COVID-19 pandemic, a decrease in histopathological diagnoses at the dermatopathology ward in our hospital was observed, for both benign and malignant pathologies, especially for NMSCs and melanomas, compared to the same period 1 year prior to the pandemic.https://www.mdpi.com/1648-9144/57/6/533COVID-19 pandemicnon-melanocytic cancershistopathology
spellingShingle Iuliu-Gabriel Cocuz
Maria-Elena Cocuz
Raluca Niculescu
Mihaela Cornelia Șincu
Andreea Cătălina Tinca
Adrian-Horațiu Sabău
Diana Maria Chiorean
Silviu Horia Morariu
Ovidiu Simion Cotoi
The Impact of and Adaptations Due to the COVID-19 Pandemic on the Histopathological Diagnosis of Skin Pathologies, Including Non-Melanocyte and Melanoma Skin Cancers—A Single-Center Study in Romania
Medicina
COVID-19 pandemic
non-melanocytic cancers
histopathology
title The Impact of and Adaptations Due to the COVID-19 Pandemic on the Histopathological Diagnosis of Skin Pathologies, Including Non-Melanocyte and Melanoma Skin Cancers—A Single-Center Study in Romania
title_full The Impact of and Adaptations Due to the COVID-19 Pandemic on the Histopathological Diagnosis of Skin Pathologies, Including Non-Melanocyte and Melanoma Skin Cancers—A Single-Center Study in Romania
title_fullStr The Impact of and Adaptations Due to the COVID-19 Pandemic on the Histopathological Diagnosis of Skin Pathologies, Including Non-Melanocyte and Melanoma Skin Cancers—A Single-Center Study in Romania
title_full_unstemmed The Impact of and Adaptations Due to the COVID-19 Pandemic on the Histopathological Diagnosis of Skin Pathologies, Including Non-Melanocyte and Melanoma Skin Cancers—A Single-Center Study in Romania
title_short The Impact of and Adaptations Due to the COVID-19 Pandemic on the Histopathological Diagnosis of Skin Pathologies, Including Non-Melanocyte and Melanoma Skin Cancers—A Single-Center Study in Romania
title_sort impact of and adaptations due to the covid 19 pandemic on the histopathological diagnosis of skin pathologies including non melanocyte and melanoma skin cancers a single center study in romania
topic COVID-19 pandemic
non-melanocytic cancers
histopathology
url https://www.mdpi.com/1648-9144/57/6/533
work_keys_str_mv AT iuliugabrielcocuz theimpactofandadaptationsduetothecovid19pandemiconthehistopathologicaldiagnosisofskinpathologiesincludingnonmelanocyteandmelanomaskincancersasinglecenterstudyinromania
AT mariaelenacocuz theimpactofandadaptationsduetothecovid19pandemiconthehistopathologicaldiagnosisofskinpathologiesincludingnonmelanocyteandmelanomaskincancersasinglecenterstudyinromania
AT ralucaniculescu theimpactofandadaptationsduetothecovid19pandemiconthehistopathologicaldiagnosisofskinpathologiesincludingnonmelanocyteandmelanomaskincancersasinglecenterstudyinromania
AT mihaelacorneliasincu theimpactofandadaptationsduetothecovid19pandemiconthehistopathologicaldiagnosisofskinpathologiesincludingnonmelanocyteandmelanomaskincancersasinglecenterstudyinromania
AT andreeacatalinatinca theimpactofandadaptationsduetothecovid19pandemiconthehistopathologicaldiagnosisofskinpathologiesincludingnonmelanocyteandmelanomaskincancersasinglecenterstudyinromania
AT adrianhoratiusabau theimpactofandadaptationsduetothecovid19pandemiconthehistopathologicaldiagnosisofskinpathologiesincludingnonmelanocyteandmelanomaskincancersasinglecenterstudyinromania
AT dianamariachiorean theimpactofandadaptationsduetothecovid19pandemiconthehistopathologicaldiagnosisofskinpathologiesincludingnonmelanocyteandmelanomaskincancersasinglecenterstudyinromania
AT silviuhoriamorariu theimpactofandadaptationsduetothecovid19pandemiconthehistopathologicaldiagnosisofskinpathologiesincludingnonmelanocyteandmelanomaskincancersasinglecenterstudyinromania
AT ovidiusimioncotoi theimpactofandadaptationsduetothecovid19pandemiconthehistopathologicaldiagnosisofskinpathologiesincludingnonmelanocyteandmelanomaskincancersasinglecenterstudyinromania
AT iuliugabrielcocuz impactofandadaptationsduetothecovid19pandemiconthehistopathologicaldiagnosisofskinpathologiesincludingnonmelanocyteandmelanomaskincancersasinglecenterstudyinromania
AT mariaelenacocuz impactofandadaptationsduetothecovid19pandemiconthehistopathologicaldiagnosisofskinpathologiesincludingnonmelanocyteandmelanomaskincancersasinglecenterstudyinromania
AT ralucaniculescu impactofandadaptationsduetothecovid19pandemiconthehistopathologicaldiagnosisofskinpathologiesincludingnonmelanocyteandmelanomaskincancersasinglecenterstudyinromania
AT mihaelacorneliasincu impactofandadaptationsduetothecovid19pandemiconthehistopathologicaldiagnosisofskinpathologiesincludingnonmelanocyteandmelanomaskincancersasinglecenterstudyinromania
AT andreeacatalinatinca impactofandadaptationsduetothecovid19pandemiconthehistopathologicaldiagnosisofskinpathologiesincludingnonmelanocyteandmelanomaskincancersasinglecenterstudyinromania
AT adrianhoratiusabau impactofandadaptationsduetothecovid19pandemiconthehistopathologicaldiagnosisofskinpathologiesincludingnonmelanocyteandmelanomaskincancersasinglecenterstudyinromania
AT dianamariachiorean impactofandadaptationsduetothecovid19pandemiconthehistopathologicaldiagnosisofskinpathologiesincludingnonmelanocyteandmelanomaskincancersasinglecenterstudyinromania
AT silviuhoriamorariu impactofandadaptationsduetothecovid19pandemiconthehistopathologicaldiagnosisofskinpathologiesincludingnonmelanocyteandmelanomaskincancersasinglecenterstudyinromania
AT ovidiusimioncotoi impactofandadaptationsduetothecovid19pandemiconthehistopathologicaldiagnosisofskinpathologiesincludingnonmelanocyteandmelanomaskincancersasinglecenterstudyinromania